π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-09-05
Trial ID
NCT07102901
Treatments Being Tested
This is an open-label, two-part study to evaluate the safety, tolerability,...
Status
Completed
Location
Montefiore-Einstein Center for Cancer Care
Start Date
2020-09-07
Trial ID
NCT04446260
Treatments Being Tested
This is a multicenter, two-arm, exploratory clinical study designed to eval...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2026-05
Trial ID
NCT07528898
Treatments Being Tested
This is an open-label, phase II study evaluating the efficacy and safety of...
Status
Recruiting
Location
Shengjing Hospital affiliated to China Medical University
Start Date
2024-08-23
Trial ID
NCT06340230
To evaluate the efficacy and safety of Serplulimab in combination with Tras...
Status
Not Yet Recruiting
Location
the First Affiliated Hospital of the Air Force Medical University
Start Date
2026-03-25
Trial ID
NCT07466303
Treatments Being Tested
This study is an open, multicenter Phase I/II clinical trial, divided into ...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2025-11-20
Trial ID
NCT07231211
Treatments Being Tested
This is a prospective, multicenter, open-label, randomized, controlled Stud...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07417241
Treatments Being Tested
This is an open-label, two-part study to evaluate the safety and efficacy o...
Status
Unknown
Location
Qilu Hospital of Shandong University
Start Date
2023-07-10
Trial ID
NCT05896020
Treatments Being Tested
This study is a multicenter, randomized, open-label, parallel Phase III cli...
Status
Active Not Recruiting
Location
Shengjing Hospital, China Medical University
Start Date
2025-10-23
Trial ID
NCT07196774
This study aims to evaluate the efficacy and safety of SHR-A1811 combined w...
Status
Recruiting
Location
The First Hospital of China Medical University
Start Date
2025-08-18
Trial ID
NCT07118527